Natixis Advisors, L.P. Neogenomics Inc Transaction History

Natixis Advisors, L.P.

$53.5 Billion
Q4 2024

A detailed history of Natixis Advisors, L.P. transactions in Neogenomics Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 36,976 shares of NEO stock, worth $352,011. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,976

Previous 33,982 8.81%

Holding current value

$352,011

Previous $501,000 21.56%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$13.0 - $18.43 $38,922 - $55,179	2,994 Added 8.81%	36,976 $609,000
Q3 2024 Nov 06, 2024	BUY	$13.4 - $17.73 $159,942 - $211,625	11,936 Added 54.14%	33,982 $501,000
Q2 2024 Aug 01, 2024	SELL	$13.01 - $15.77 $111,886 - $135,622	-8,600 Reduced 28.06%	22,046 $306,000
Q1 2024 Apr 25, 2024	SELL	$14.06 - $16.79 $122,518 - $146,308	-8,714 Reduced 22.14%	30,646 $482,000
Q4 2023 Feb 06, 2024	BUY	$11.67 - $20.73 $233,516 - $414,807	20,010 Added 103.41%	39,360 $636,000
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $26,875 - $39,484	-2,212 Reduced 10.26%	19,350 $238,000
Q2 2023 Aug 15, 2023	BUY	$14.1 - $19.83 $69,893 - $98,297	4,957 Added 29.85%	21,562 $347,000
Q1 2023 May 11, 2023	BUY	$9.09 - $19.45 $150,939 - $322,967	16,605 New	16,605 $289,000
Q1 2022 May 12, 2022	SELL	$12.15 - $35.28 $156,054 - $453,136	-12,844 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$30.49 - $48.49 $435,519 - $692,631	-14,284 Reduced 52.65%	12,844 $438,000
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $402,768 - $507,763	9,668 Added 55.37%	27,128 $1.31 Million
Q2 2021 Aug 12, 2021	SELL	$36.62 - $51.69 $101,803 - $143,698	-2,780 Reduced 13.74%	17,460 $789,000
Q1 2021 May 05, 2021	BUY	$41.56 - $59.88 $370,756 - $534,189	8,921 Added 78.81%	20,240 $976,000
Q4 2020 Feb 12, 2021	BUY	$36.08 - $56.47 $408,389 - $639,183	11,319 New	11,319 $609,000

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.2B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Neogenomics Inc Transaction History